Castañeda SJJ, Castell CHR, Mille LJE, Catalán QG

Language: Spanish
References: 8
Page: 171-176
PDF size: 110.14 Kb.

ABSTRACT

Introduction. TURP is considered up to now the election treatment for BPH. Nevertheless, the need for hospitalization and its complications has made us look for less invasive options with equal results but with less morbidity. Objective. Show our experience with TUNA, publish the technique and compare our results. Material and methods. From August 2003 to July 2004 we treated 14 patients with TUNA for BPH. All of them had pre and pos-treatment QMAX, suprapubic US with measures of the residual volume and PSA. The symptoms were evaluated according to IPSS and QOL. Results. The average age was 53.7 years. In all cases the IPSS and vol. resid diminished. There was an important improvement in QMAX and QOL. Conclusions. TUNA is and excellent alternative for the symptomatic BPH. It should be considered as a first line treatment for LUTS because the possibility of being done in the office, it’s high security and few complications.

REFERENCES

1. Graves E. Vital Health Stats 1992; 13: 117.

2. Mebust W, Holtgrewe H, Cockett A, Peters P, Writing Comitte. Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243.

3. Muta MI, Myrick S, Symbas N. The TUNA procedure for BPH: review of the technology. Inf in Urol 1998; July/Aug.

4. Steele GS, Sleep D. Transurethral needle ablation of the prostate: does the preassure flow curve change? J Urol 1995; 153(Suppl.): 328A.

5. Zlotta A, Deny M, Matos C, Schulman C. Transurethral needle ablation of the prostate: clinical experience in patients in urinary acute retention. Br J Urol 1996; 77: 391-7.

6. Zlotta A, Giannakopoulos X, Maehlum O, Ostrem T, Schulman C. Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for the treatment of symptomatic prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol 2003; 44: 89-93.

7. Hill B, Belville W, Bruskewitz R, Issa M, Perez Marrero R, Roehrborn C, Terris M, Naslund M. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5 year results of a prospective, randomized, multicenter clinical trial. J Urol 2004; 171: 2336-40.

8. Naslund M. Transurethral needle ablation of the prostate. Urol 1997; 50(2): 167-72.